Joint Programming Initiative on Antimicrobial Resistance
 

This will be replaced with the Google Map.

Germany

Infectious diseases are the most common cause of death worldwide. In Germany, more than 40,000 people died of the consequences of an infection in 2006. Since the percentage of resistant pathogens has risen in recent years, and a further increase cannot be ruled out, a targeted approach is needed to reduce antimicrobial resistance and strengthen preventive measures at the local, regional and national level. The containment of antimicrobial resistance necessitates a comprehensive examination of the problem, since antimicrobial resistance occurs both in the field of human medicine and in veterinary medicine. Consequently, an Antimicrobial Resistance Strategy for Germany was developed in 2011 (http://www.bmg.bund.de/fileadmin/dateien/Publikationen/Gesundheit/Sonstiges/DART_-_German_Antimicrobial_Resistance_Strategy.pdf)
Thus, besides the national engagement in research in this field and the implementation of a German Antibiotic Resistance Strategy, coordinating and strengthening the European research efforts is a particular concern.
Germany represented by the Federal Ministry of Education and Research (BMBF) is partner in the development and implementation of JPI-AMR.

Your Name (required)

Your Email (required)

Subject

Your Message

Connect with us socially
facebooktwitter

Lorem ipsum dolor sit amot, consectetur adipisicing elit, sed do eiusmod tempor incididunt.

Share this page
Tweet about this on TwitterShare on FacebookShare on Google+